Aminotransferase activity and acarbose treatment in patients with type 2 diabetes [2]

Diabetes Care

Volumn 22, Issue 7, 1999, Pages 1217-1218

  Gentile, Sandro ^a,b   Turco, Salvatore ^a   Guarino, Giuseppina ^a   Sasso, Ferdinando C ^a   Torella, Roberto ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALCOHOL; AMINOTRANSFERASE; FLUPHENAZINE; GLIBENCLAMIDE;

ALCOHOL CONSUMPTION; AMINOTRANSFERASE BLOOD LEVEL; CELL DEATH; DRUG USE; ENZYME ACTIVITY; HEPATOMEGALY; HUMAN; INFECTION RISK; INFECTIOUS HEPATITIS; LETTER; LIVER CIRRHOSIS; LIVER INJURY; LIVER TOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS;

ACARBOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; TRANSAMINASES; TRISACCHARIDES;

EID: 0033047799     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.7.1217     Document Type: Letter

References (5)

1. Carrascosa M, Pascual F, Aresti S: Acarbose-induced acute severe hepatotoxicity. Lancet 349:698-699, 1997
2. Andrade RL, Lucena MI, Rodriguez-Mendizabar M: Hepatic injury caused by acarbose (Letter). Ann Int Med 125:931, 1996
3. Acarbose for diabetes mellitus (Editorial). Med Lett 38:9-10, 1996
4. Gentile S, Turco S, Rossi E, Torella R: Non-insulin-dependent diabetes mellitus and liver cirrhosis: effect of treatment with acarbose. In Front Diabetes. Belfiore F, Lorenzi M, Molinatti GM, Porta M, Eds. Basel, Karger, 1998, p. 167-171
5. Lee WM: Drug-induced hepatotoxicity. N Engl J Med 333:1118-1127, 1995